Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
INR 15.2
(-4.94%)
INR 15.2
(-4.94%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -68.26 Million INR | -715.83% |
| 2022 | 11.08 Million INR | -64.09% |
| 2021 | 30.86 Million INR | -66.69% |
| 2020 | 92.66 Million INR | 16.92% |
| 2019 | 79.25 Million INR | 28.71% |
| 2018 | 61.57 Million INR | 67.39% |
| 2017 | 36.78 Million INR | 855.28% |
| 2016 | -4.87 Million INR | 71.49% |
| 2015 | -17.08 Million INR | -383.16% |
| 2014 | 6.03 Million INR | 397.22% |
| 2013 | -2.02 Million INR | -102.02% |
| 2012 | 100.38 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 258.42% |
| 2023 Q2 | -70.79 Million INR | -278.18% |
| 2023 Q1 | 39.73 Million INR | 258.42% |
| 2023 Q3 | 93.86 Million INR | 232.59% |
| 2023 FY | -68.26 Million INR | -715.83% |
| 2023 Q4 | -68.26 Million INR | -172.73% |
| 2022 Q1 | 853 Thousand INR | -97.41% |
| 2022 Q3 | 11.15 Million INR | 81.13% |
| 2022 Q4 | 11.08 Million INR | -0.62% |
| 2022 FY | 11.08 Million INR | -64.09% |
| 2022 Q2 | 6.15 Million INR | 621.92% |
| 2021 Q4 | 32.91 Million INR | 11696.06% |
| 2021 Q1 | 4.1 Million INR | -95.57% |
| 2021 Q3 | 279 Thousand INR | -99.73% |
| 2021 FY | 30.86 Million INR | -66.69% |
| 2021 Q2 | 104.41 Million INR | 2445.44% |
| 2020 Q4 | 92.66 Million INR | 7306.95% |
| 2020 FY | 92.66 Million INR | 16.92% |
| 2020 Q1 | 48.65 Million INR | -38.61% |
| 2020 Q2 | 94.84 Million INR | 94.95% |
| 2020 Q3 | 1.25 Million INR | -98.68% |
| 2019 FY | 79.25 Million INR | 28.71% |
| 2019 Q1 | 2.49 Million INR | -95.71% |
| 2019 Q4 | 79.25 Million INR | 0.0% |
| 2018 Q4 | 58.08 Million INR | 0.0% |
| 2018 Q2 | 46.36 Million INR | 13461.38% |
| 2018 Q1 | -347 Thousand INR | -100.99% |
| 2018 FY | 61.57 Million INR | 67.39% |
| 2017 FY | 36.78 Million INR | 855.28% |
| 2017 Q3 | 1.6 Million INR | -91.71% |
| 2017 Q2 | 19.37 Million INR | 272.08% |
| 2017 Q1 | 5.2 Million INR | 206.91% |
| 2017 Q4 | 35.19 Million INR | 2090.07% |
| 2016 Q1 | -8.26 Million INR | 51.61% |
| 2016 FY | -4.87 Million INR | 71.49% |
| 2016 Q4 | -4.87 Million INR | 57.99% |
| 2016 Q3 | -11.59 Million INR | 20.03% |
| 2016 Q2 | -14.49 Million INR | -75.41% |
| 2015 Q2 | -5.44 Million INR | -60.89% |
| 2015 FY | -17.08 Million INR | -383.16% |
| 2015 Q4 | -17.08 Million INR | -249.74% |
| 2015 Q3 | -4.88 Million INR | 10.32% |
| 2015 Q1 | -3.38 Million INR | -156.11% |
| 2014 Q4 | 6.03 Million INR | -51.35% |
| 2014 Q1 | 1 Million INR | 149.37% |
| 2014 FY | 6.03 Million INR | 397.22% |
| 2014 Q3 | 12.4 Million INR | 42.53% |
| 2014 Q2 | 8.7 Million INR | 768.26% |
| 2013 Q3 | 100.78 Million INR | -0.19% |
| 2013 Q4 | -2.02 Million INR | -102.01% |
| 2013 FY | -2.02 Million INR | -102.02% |
| 2013 Q2 | 100.98 Million INR | -0.33% |
| 2013 Q1 | 101.31 Million INR | 0.93% |
| 2012 Q4 | 100.38 Million INR | 6909.88% |
| 2012 Q3 | 1.43 Million INR | -98.63% |
| 2012 Q2 | 104.31 Million INR | 0.0% |
| 2012 FY | 100.38 Million INR | 0.0% |
| 2011 Q4 | 104.53 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.21 Million INR | 370.749% |
| Sastasundar Ventures Limited | -297.24 Million INR | 77.034% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 115.812% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | -52.978% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 10.358% |
| Sunil Healthcare Limited | 625.4 Million INR | 110.915% |
| MedPlus Health Services Limited | 8.67 Billion INR | 100.787% |
| Patidar Buildcon Limited | 25.12 Million INR | 371.691% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 20.576% |
| Roopa Industries Limited | 216.01 Million INR | 131.602% |
| Smruthi Organics Limited | 111.28 Million INR | 161.34% |
| Trident Lifeline Limited | 117.56 Million INR | 158.068% |
| Bacil Pharma Limited | 569 Thousand INR | 12097.364% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | 283.075% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | 280.767% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | 607.735% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | -497.244% |
| Tyche Industries Limited | -788.94 Million INR | 91.347% |
| Zenlabs Ethica Limited | 139.54 Million INR | 148.919% |
| Vikram Thermo (India) Limited | 38.62 Million INR | 276.738% |
| ANG Lifesciences India Limited | 671.01 Million INR | 110.173% |
| Parmax Pharma Limited | 51.8 Million INR | 231.76% |
| Deccan Health Care Limited | -7.07 Million INR | -864.74% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 106.52% |
| Makers Laboratories Limited | 172.59 Million INR | 139.553% |
| Lactose (India) Limited | 373.97 Million INR | 118.254% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | -1026.857% |
| Zenith Healthcare Limited | -25.45 Million INR | -168.158% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 151.677% |
| Mercury Laboratories Limited | -26.72 Million INR | -155.397% |
| Gennex Laboratories Limited | -552.54 Million INR | 87.645% |
| PRAVEG LIMITED | -434.98 Million INR | 84.306% |
| Denis Chem Lab Limited | -236.28 Million INR | 71.109% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 109.902% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 107.406% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 91.38% |
| PANJON LTD. | -12.8 Million INR | -432.987% |
| Trimurthi Limited | -1.17 Million INR | -5694.008% |
| Colinz Laboratories Limited | -64.3 Million INR | -6.161% |
| Godavari Drugs Limited | 530.02 Million INR | 112.88% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | -633.244% |
| Zenotech Laboratories Limited | -196.85 Million INR | 65.323% |
| Panchsheel Organics Limited | -157.82 Million INR | 56.745% |
| Anuh Pharma Limited | -69.8 Million INR | 2.209% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 133.818% |
| Crestchem Limited | -1.45 Million INR | -4607.931% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | -12.404% |
| Vivanza Biosciences Limited | 50.02 Million INR | 236.459% |
| Phaarmasia Limited | -4.89 Million INR | -1294.017% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 106.539% |
| Bharat Parenterals Limited | 1.48 Billion INR | 104.586% |
| Norris Medicines Limited | 214.86 Million INR | 131.772% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 26.706% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | -26.689% |
| Veerhealth Care Limited | -2.38 Million INR | -2762.264% |
| BDH Industries Limited | -164.47 Million INR | 58.494% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 186.736% |
| Beryl Drugs Limited | 48.7 Million INR | 240.152% |
| Evoq Remedies Limited | 41.14 Million INR | 265.901% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 111.948% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 158.724% |
| Transchem Limited | -3.16 Million INR | -2058.236% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | -41.929% |
| Parnax Lab Limited | 787.61 Million INR | 108.667% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | -16.521% |
| Kerala Ayurveda Limited | 447.82 Million INR | 115.244% |
| Cian Healthcare Limited | 544.97 Million INR | 112.526% |
| Trinity League India Limited | -12 Thousand INR | -568775.0% |
| Syschem (India) Limited | 3.53 Million INR | 2032.758% |
| Medi-Caps Limited | -3.21 Million INR | -2023.989% |
| Coral Laboratories Limited | -612.82 Million INR | 88.861% |
| Concord Drugs Limited | 164.48 Million INR | 141.502% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 104.893% |
| Natural Capsules Limited | 956.68 Million INR | 107.136% |
| Auro Laboratories Limited | 252.51 Million INR | 127.034% |